Characteristics | Total (n = 54) | NRT group (n = 28) | NCRT group (n = 26) |
---|---|---|---|
Gender | |||
Male | 42 (77.8%) | 22 (78.57%) | 20 (76.92%) |
Female | 12 (22.2%) | 6 (21.43%) | 6 (23.08%) |
Age | |||
70–79 years old | 41 (75.9%) | 16 (57.14%) | 25 (96.15%) |
More than 80 years old | 13 (24.1%) | 12 (42.86%) | 1 (3.85%) |
KPS | |||
70–80 | 28 (51.9%) | 19 (67.86%) | 9 (34.62%) |
90–100 | 26 (48.1%) | 9 (32.14%) | 17 (65.38%) |
Location of the tumor | |||
Upper esophagus | 8 (14.8%) | 2 (7.14%) | 6 (23.08%) |
Middle esophagus | 28 (51.9%) | 16 (57.14%) | 12 (46.15%) |
Lower esophagus | 18 (33.3%) | 10 (35.72%) | 8 (30.77%) |
Stage of T | |||
T1 | 3 (5.6%) | 1 (3.57%) | 2 (7.69%) |
T2 | 12 (22.2%) | 5 (17.86%) | 7 (26.92%) |
T3 | 22 (40.7%) | 14 (50.00%) | 8 (30.77%) |
T4 | 17 (31.5%) | 8 (28.57%) | 9 (34.62%) |
Stage of N | |||
N0 | 16 (29.6%) | 8 (28.57%) | 8 (30.77%) |
N1 | 18 (33.3%) | 12 (42.86%) | 6 (23.08%) |
N2 | 19 (35.2%) | 8 (28.57%) | 11 (42.31%) |
N3 | 1 (1.9%) | 0 (0) | 1 (3.84%) |
Tumor stage | |||
I | 3 (5.5%) | 1 (3.57%) | 2 (7.70%) |
II | 11 (20.4%) | 7 (25.00%) | 4 (15.38%) |
III | 21 (38.9%) | 11 (39.29%) | 10 (38.46%) |
Iva | 19 (35.2%) | 9 (32.14%) | 10 (38.46%) |
Smoking | 37 (68.52%) | 19 (67.86%) | 18 (69.23%) |